THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION
https://doi.org/10.15829/1728-8800-2015-5-78-82
Abstract
Noncompacted myocardium of the left ventricle (NMLV), or noncompacted cardiomyopathy, according to the World Health Organization classification is a non-classified cardiomyopathy with not fully known origins. This type of cardiomyopathy presents with an increased trabecularity with deep intertrabecular sinuses in the LV. NMLV exists as either isolated or together with other inherited syndromes. Clinical presentation of NMLV varies: there are asymptomatic forms, or those with progression of the disease, with heart failure, angina, thromboembolism, life-threatening ventricular rhythm disorders; in some cases, the disease manifests as sudden cardiac death. At the same time, there is a problem of NMLV decompensation, with significant impact of acute myocarditis comorbidity. The article presents a case of the female patient, whose disease presented with heart failure at the background of acute myocarditis and further onset of everything for NMLV.
About the Authors
R. P. MyasnikovRussian Federation
O. V. Blagova
Russian Federation
O. V. Kulikova
Russian Federation
E. A. Mershina
Russian Federation
M. S. Kharlap
Russian Federation
E. Yu. Andreenko
Russian Federation
S. N. Koretsky
Russian Federation
S. E. Serdyuk
Russian Federation
E. V. Bazaeva
Russian Federation
I. A. Virabova
Russian Federation
S. A. Beregovskaya
Russian Federation
V. E. Sinitsyn
Russian Federation
S. A. Boytsov
Russian Federation
References
1. Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium: A study of eight cases. Circulation 1990; 82: 507-13.
2. Ritter M, Oechslin E, Sutsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo ClinProc 1997; 72: 26-31.
3. Freedom RM, Yoo SJ, Perrin D, et al. The morphological spectrum of ventricular noncompaction. Cardiol Young 2005; 15: 345-64.
4. Toyono M, Kondo C, Nakajima Y et al. Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction. Heart 2001; 86: E4.
5. Stollberger C and Finsterer J. Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr 2004; 17: 91-100.
6. Oechslin E and Jenni R. Left ventricular noncompaction revisited: a distinct phenotype with genetic heterogeneity? Eur Heart J 2011; 32: 1446-56.
7. Bhatia NL, Tajik AJ, Wilansky S, et al. Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview. J Card Fail 2011; 17: 771-8.
8. Cevik C and Stainback RF. Isolated left ventricular noncompaction in a 90-year-old man. Tex Heart Inst J 2012; 39: 255-7.
9. Udeoji DU, Philip KJ, Morrissey RP, et al. Left ventricular noncompaction cardiomyopathy: updated review. Ther Adv Cardiovasc Dis 2013; 7: 260-73.
10. GCiveng TS, Erer HB, Altay S, et al. 'Idiopathic' acute myocardial infarction in a young patient with noncompaction cardiomyopathy. Cardiol J 2012; 19(4): 429-33.
11. Basic D, Gupta S, Kwong RY. Parvovirus b19-induced myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging. Circulation 2010; 121(7): e40-2.
12. Kiihl U, Pauschinger M, Bock T, et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003; 108(8): 945-50.
13. Maisch B, Pankuweit S. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev 2013; 18(6): 761-95.
14. Faria R, Pereira S, Santos W, et al. [Fulminant myocarditis]. [Article in Portuguese] Rev Port Cardiol 2012; 31(7-8): 503-7.
15. Fazio G, Corrado G, Zachara E, et al. Anticoagulant drugs in noncompaction: a mandatory therapy? J Cardiovasc Med (Hagerstown) 2008; 9(11): 1095-7.
16. Finsterer J, Stollberger C, Molzer G, et al. Cerebrovascular events in left ventricular hypertrabeculation/noncompaction with and without myopathy. Int J Cardiol 2008; 130(3): 344-8.
17. Jenni R, Wyss CA, Oechslin EN, et al. Isolated ventricular noncompaction is associated with coro- nary microcirculatory dysfunction. JACC 2002; 39: 450-4.
Review
For citations:
Myasnikov R.P., Blagova O.V., Kulikova O.V., Mershina E.A., Kharlap M.S., Andreenko E.Yu., Koretsky S.N., Serdyuk S.E., Bazaeva E.V., Virabova I.A., Beregovskaya S.A., Sinitsyn V.E., Boytsov S.A. THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION. Cardiovascular Therapy and Prevention. 2015;14(5):78-82. (In Russ.) https://doi.org/10.15829/1728-8800-2015-5-78-82